Vigilancia epidemiológica de la enfermedad neumocócica invasiva y factores asociados a patogenicidad

Referencias bibliográficas

• de Miguel S, Domenech M, González-Camacho F, Sempere J, Vicioso D, Sanz JC, García Comas L, Ardanuy C, Fenoll A, Yuste J. Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era. Clin Infect Dis. 2020:ciaa1483.
• Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M. Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain. Front Microbiol. 2020; 11: 309.
• Tarancón R, Domínguez-Andrés J, Uranga S, Ferreira AV, Groh LA, Domenech M, González-Camacho F, Riksen NP, Aguilo N, Yuste J, Martín C, Netea MG. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia. PLoS Pathog. 2020; 16(4):e1008404.
• Domenech M, Sempere J, de Miguel S, Yuste J. Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract. Front Immunol. 2018; 9:2700.
• Corsini B, Díez-Martínez R, Aguinagalde L, González-Camacho F, García-Fernández E, Letrado P, García P, Yuste J. Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract. Antimicrob Agents Chemother. 2018 25;62 (6).
• Corsini B, Aguinagalde L, Ruiz S, Domenech M, Antequera ML, Fenoll A, García P, García E, Yuste J. Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis. Vaccine. 2016; 34 (50):6148-6157.
• Ramos-Sevillano E, Urzainqui A, de Andrés B, González-Tajuelo R, Domenech M, González-Camacho F, Sánchez-Madrid F, Brown JS, García E,Yuste J. PSGL-1 on leukocytes is a critical component of the host immune response against invasive pneumococcal disease. PLoS Pathog. 2016;12 (3): e1005500.
• Aguinagalde L, Corsini B, Domenech A, Domenech M, Cámara J, Ardanuy C, García E, Liñares J, Fenoll A, Yuste J. Emergence of amoxicillin-resistant variants of Spain9V-ST156 pneumococci expressing serotype 11A correlates with their ability to evade the host immune response. PLoS One. 2015;10 (9): e0137565.
• Aguinagalde L, Díez-Martínez R, Yuste J, Royo I, Gil C, Lasa Í, Martín-Fontecha M, Marín-Ramos NI, Ardanuy C, Liñares J, García P, García E, Sánchez-Puelles JM. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections. J Antimicrob Chemother. 2015; 70(9): 2608-17
• Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, Rodríguez de Córdoba S, Sánchez-Madrid F, Brown JS, García E, Yuste J. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect Immun. 2015; 83 (2): 591-603.
• Domenech M, Damian D, Ardanuy C, Liñares J, Fenoll A, García E. Emerging non-PCV13 serotypes 11A and 35B of Streptococcus pneumoniae show high potential for biofilm formation in vitro. PLoS One. 2015; 10(4): e0125636.